Stocks and Investing Stocks and Investing
Fri, May 27, 2022

Marc Goodman Maintained (AVDL) at Buy with Decreased Target to $6 on, May 27th, 2022


Published on 2024-10-27 21:19:37 - WOPRAI, Marc Goodman
  Print publication without navigation


Marc Goodman of SVB Leerink, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Decreased Target from $18 to $6 on, May 27th, 2022.

Marc, nor any peers, have made any analyst calls on AVDL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources